Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Pneumoconiosis
Chronic beryllium disease
Chronic beryllium disease (CBD) is a granulomatous, interstitial lung disease that occurs in individuals who develop beryllium sensitization (BeS), a cell-mediated immune response to environmental and occupational beryllium exposure. BeS precedes the lung disease that may present with chronic dry cough, fatigue, weight loss, chest pain, and increasing dyspnea.
This condition has no sub-types.